Clari
ClariTrial
Built by Johnny Rice
Search
Explore
Companies
Targets
Safety
Pipeline
Competitive
Emerging
Map
Parsing your search query…
Explore
/
Monte Rosa Therapeutics
Search
Status
Recruiting
Active
Not Yet
Completed
Terminated
Phase
Early Ph 1
Phase 1
Phase 2
Phase 3
Phase 4
N/A
7
results for
“Monte Rosa Therapeutics”
NCT06597799
Completed
First-in-human Study of MRT-6160 in Healthy Subjects
Phase 1
Healthy Volunteers
MRT-6160
Placebo
Monte Rosa Therapeutics, Inc
108 participants
2 sites · United States
Completes Apr 2025
More detail
Compare
CT.gov
Full analysis →
NCT02176369
Completed
Maintenance Low Dose Oral Navelbine In Patients With Non Small Cell Lung Cancer - MA.NI.LA Trial
Phase 2
Non-small Cell Lung Cancer Stage IIIB
Non-small Cell Lung Cancer Stage IV
Vinorelbine
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
120 participants
20 sites · Italy
Completes Oct 2018
More detail
Compare
CT.gov
Full analysis →
NCT05546268
Active
Study of Oral MRT-2359 in Selected Cancer Patients
Phase 1
Phase 2
NSCLC
SCLC
High Grade Neuroendocrine Cancer
Oral MRT-2359
Oral MRT-2359
Oral MRT-2359
+3 more
Monte Rosa Therapeutics, Inc
174 participants
17 sites · United States
Completes May 2026
More detail
Compare
CT.gov
Full analysis →
NCT05611931
Recruiting
Selinexor in Maintenance Therapy After Systemic Therapy for Participants With p53 Wild-Type, Advanced or Recurrent Endometrial Carcinoma
Phase 3
Endometrial Cancer
Selinexor
Matching Placebo for selinexor
Karyopharm Therapeutics Inc
276 participants
217 sites · United States, Australia, Belgium
Completes Aug 2026
More detail
Compare
CT.gov
Full analysis →
NCT00924833
Completed
Results posted
Effects of Nebivolol Versus Carvedilol on Cardiopulmonary Function at High Altitude in Healthy Subjects.
Phase 4
Hypoxia
Altitude
Heart Failure
placebo
Carvedilol
Nebivolol
Istituto Auxologico Italiano
27 participants
1 site · Italy
Completes Nov 2006
More detail
Compare
CT.gov
Full analysis →
NCT00637325
UNKNOWN
Trastuzumab Optimization Trial in Breast Cancer
Phase 3
Metastatic or Locally Advanced Breast Cancer
trastuzumab
Regione Lombardia
500 participants
25 sites · Italy
Completes May 2009
More detail
Compare
CT.gov
Full analysis →
NCT07119125
Recruiting
A First-in-human, 3-part Study of MRT-8102 in Healthy Participants and Participants at Cardiovascular Risk With Elevated CRP
Phase 1
Healthy Volunteers
Elevated CRP
MRT-8102
Placebo
Monte Rosa Therapeutics, Inc
100 participants
4 sites · United States
Completes Jan 2026
More detail
Compare
CT.gov
Full analysis →
Previous
1–7 of 7
Next